DekaBank Deutsche Girozentrale
AKYA

DekaBank Deutsche Girozentrale’s Akoya BioSciences AKYA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-55,000
Closed -$447K – 1252
2023
Q1 		$447K Hold
55,000
– – ﹤0.01% 1030
2022
Q4 		$522K Buy
+55,000
New +$677K ﹤0.01% 1025

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

DekaBank Deutsche Girozentrale's AKYA Position: Q2 2023 in Review

DekaBank Deutsche Girozentrale sold out of Akoya BioSciences (AKYA) in Q2 2023, closing a stake of 55,000 shares — an estimated $447K sold.

DekaBank Deutsche Girozentrale first reported a position in AKYA in Q4 2022 and held it in 2 quarters. The position peaked at $522K in Q4 2022. 73 funds tracked by Wall St. Rank hold AKYA as of Q2 2023.

  • DekaBank Deutsche Girozentrale reported no remaining Akoya BioSciences position as of Q2 2023 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 55,000 Akoya BioSciences shares in Q2 2023, an estimated $447K.
  • DekaBank Deutsche Girozentrale first reported a position in Akoya BioSciences in Q4 2022 and held it in 2 quarters.
  • DekaBank Deutsche Girozentrale's Akoya BioSciences position peaked at $522K in Q4 2022.
  • 73 funds tracked by Wall St. Rank held Akoya BioSciences as of Q2 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2023, filed 25 Jul 2023.